LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diagnostic Test Kit Offers Easy Identification of Virulent Pathogens

By LabMedica International staff writers
Posted on 12 Jan 2017
Image: Fluorescence from on-chip Recombinase Polymerase Amplifications assay for Staphylococcus aureus (Photo courtesy of Leibniz Institute of Polymer Research).
Image: Fluorescence from on-chip Recombinase Polymerase Amplifications assay for Staphylococcus aureus (Photo courtesy of Leibniz Institute of Polymer Research).
A technology gap associated with commercially available diagnostic tests in remote and underdeveloped regions prevents timely pathogen identification for effective antibiotic chemotherapies for infected patients.

A portable detection system has been developed that can rapidly identify some of the most virulent, often multi-drug resistant pathogens. This device was designed to be used in places where laboratory resources are lacking, such as isolated villages in developing countries.

An international team of scientists led by those from the University of Wisconsin-Madison developed a new battery powered detection system which is small and simple. Sixteen microchambers each contain a genetic sequence from one of the sixteen pathogens the device is designed to detect. When one of these sequences matches a sequence from a patient sample, a fluorescent light illuminates from within the relevant microchamber.

The investigators picked the sequences the device uses by screening the genomes of the relevant bacteria for unique genetic sequences. Pathogens can be identified using single drops of patient samples from blood, urine, or other bodily fluids. The system can identify Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and various species of the genus, Enterobacter.

To perform Recombinase Polymerase Amplification (RPA) assays in the B-chip, the team added the isothermal RPA mix including species specific primers, fluorescent exoprobe, and buffer to the TwistAmp exo kit lyophilized enzyme pellet using the TwistDX protocol. The investigators used microplate assays to assess the performance of RPA assays for detecting E. faecium, S. aureus, K. pneumoniae, A. baumannii, and P. aeruginosa. This very sensitive assay can provide positive identification with patient samples containing as few as 10 DNA sequences. They designed a portable B-chip detection system for measuring assay fluorescence containing an excitation source, camera, incubation heater, fluorescence filters and software to control the individual components.

The authors concluded that the combination of a simple and portable cartridge-based RPA assays and a versatile electronic reader that can be used to perform assays in the field. Using de-gas driven cartridges provides a unique platform for packaging RPA assays that can simplify their use and potentially reduce contamination by packaging and compartmentalization. The study was published on December 16, 2016, in the journal Applied and Environmental Microbiology.

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Gold Member
Collection and Transport System
PurSafe Plus®

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more